Modali R - Search Results

1

Fc gamma RIIIa and Fc gamma RIIa polymorphisms do not predict response to rituximab in B-cell chronic lymphocytic leukemia.

Farag SS, Flinn IW, Modali R, Lehman TA, Young D, Byrd JC. Farag SS, et al. Among authors: modali r. Blood. 2004 Feb 15;103(4):1472-4. doi: 10.1182/blood-2003-07-2548. Epub 2003 Oct 16. Blood. 2004. PMID: 14563637 Free article. Clinical Trial.

2

FCGR3A and FCGR2A polymorphisms may not correlate with response to alemtuzumab in chronic lymphocytic leukemia.

Lin TS, Flinn IW, Modali R, Lehman TA, Webb J, Waymer S, Moran ME, Lucas MS, Farag SS, Byrd JC. Lin TS, et al. Among authors: modali r. Blood. 2005 Jan 1;105(1):289-91. doi: 10.1182/blood-2004-02-0651. Epub 2004 Jun 24. Blood. 2005. PMID: 15217834 Free article. Clinical Trial.

3

Screening of mutations in the ras family of oncogenes by polymerase chain reaction-based ligase chain reaction.

Martínez A, Lehman TA, Modali R, Mulshine JL. Martínez A, et al. Among authors: modali r. Methods Mol Med. 2003;74:187-200. doi: 10.1385/1-59259-323-2:187. Methods Mol Med. 2003. PMID: 12415694 No abstract available.

4

Polynucleotide kinase 3' phosphatase variant, dietary variables and risk of adenoma recurrence in the Polyp Prevention Trial.

Murphy G, Sansbury LS, Bergen AW, Wang Z, Schatzkin A, Lehman T, Kalidindi A, Modali R, Lanza E. Murphy G, et al. Among authors: modali r. Eur J Cancer Prev. 2008 Jun;17(3):287-90. doi: 10.1097/CEJ.0b013e3282b6fdb8. Eur J Cancer Prev. 2008. PMID: 18414202 Free PMC article. Clinical Trial.

5

Dopamine D2 receptor polymorphisms and adenoma recurrence in the Polyp Prevention Trial.

Murphy G, Cross AJ, Sansbury LS, Bergen A, Laiyemo AO, Albert PS, Wang Z, Yu B, Lehman T, Kalidindi A, Modali R, Schatzkin A, Lanza E. Murphy G, et al. Among authors: modali r. Int J Cancer. 2009 May 1;124(9):2148-51. doi: 10.1002/ijc.24079. Int J Cancer. 2009. PMID: 19065655 Free PMC article. Clinical Trial.

6

Folate and MTHFR: risk of adenoma recurrence in the Polyp Prevention Trial.

Murphy G, Sansbury LB, Cross AJ, Stolzenberg-Solomon R, Laiyemo A, Albert PS, Wang Z, Schatzkin A, Lehman T, Kalidindi A, Modali R, Lanza E. Murphy G, et al. Among authors: modali r. Cancer Causes Control. 2008 Sep;19(7):751-8. doi: 10.1007/s10552-008-9137-6. Epub 2008 Mar 6. Cancer Causes Control. 2008. PMID: 18322814

7

Polymorphisms of XRCC1 and risk of esophageal and gastric cardia cancer.

Ratnasinghe LD, Abnet C, Qiao YL, Modali R, Stolzenberg-Solomon R, Dong ZW, Dawsey SM, Mark SD, Taylor PR. Ratnasinghe LD, et al. Among authors: modali r. Cancer Lett. 2004 Dec 28;216(2):157-64. doi: 10.1016/j.canlet.2004.03.012. Cancer Lett. 2004. PMID: 15533591

8

Merkel cell carcinoma subgroups by Merkel cell polyomavirus DNA relative abundance and oncogene expression.

Bhatia K, Goedert JJ, Modali R, Preiss L, Ayers LW. Bhatia K, et al. Among authors: modali r. Int J Cancer. 2010 May 1;126(9):2240-6. doi: 10.1002/ijc.24676. Int J Cancer. 2010. PMID: 19551862 Free PMC article.

9

Potential role of human cytomegalovirus and p53 interaction in coronary restenosis.

Speir E, Modali R, Huang ES, Leon MB, Shawl F, Finkel T, Epstein SE. Speir E, et al. Among authors: modali r. Science. 1994 Jul 15;265(5170):391-4. doi: 10.1126/science.8023160. Science. 1994. PMID: 8023160

10

Immunological detection of viral large T antigen identifies a subset of Merkel cell carcinoma tumors with higher viral abundance and better clinical outcome.

Bhatia K, Goedert JJ, Modali R, Preiss L, Ayers LW. Bhatia K, et al. Among authors: modali r. Int J Cancer. 2010 Sep 1;127(6):1493-6. doi: 10.1002/ijc.25136. Int J Cancer. 2010. PMID: 20041469 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

43 results

Search Page

Filters